Ranjitkar Manandhar, N., Kayastha, G. K. and Acharya, P. K. (2018) “Dasatinib tyrosine kinase inhibitor as second and third line therapy in chronic myeloid leukemia: outcome of a Nepalese study”, Journal of Patan Academy of Health Sciences, 5(1), pp. 47–56. Available at: https://jpahs.edu.np/index.php/jpahs/article/view/97 (Accessed: 25 October 2024).